Once infused back into the patient, CAR-T cells circulate in the bloodstream and bind to target antigens on cancer cells. This binding activates the CAR-T cells, prompting them to release cytotoxic molecules and induce apoptosis in the cancer cells. The process culminates in the targeted destruction of cancerous tissue.
